INTERVIEWS

Dr. Karin Ried, Australian Researcher and expert in Kyolic Aged Garlic Extract, discusses the results of a recently published clinical trial that shows that Kyolic Aged Garlic Extract supports healthy blood pressure similar to blood pressure medications.

Jeff Kozloff, Chief Executive Officer at TrialScope discusses how clinical trial sponsors are seeking to connect better with patients. They have recently launched TrialScope Engage, a solution that enables sponsors to engage with patients, healthcare professionals, researchers, and the public via a dedicated clinical trial informational website in an easy to understand format.

Financial Planner, Chad Chubb discusses his niche market HENRYs (High Earning Not Rich Yet) for individuals who struggle with massive student loan debts.

ViiV Healthcare and the Latino Commission on AIDS collaborated on a study to explore strategies to improve healthcare services and HIV treatment adherence for Latino men. Findings from this study were presented in March 2019 during a late-breaking session at the Centers for Disease Control and Prevention 2019 National HIV Prevention Conference in Atlanta, GA. Marc Meachem, Head, External Affairs, ViiV Healthcare; Member, Presidential Advisory Council on HIV/AIDS and Guillermo Chacón, President, Latino Commission on AIDS discuss the study and findings.

Dr. Jens Hillengass of Roswell Park Comprehensive Cancer Center, discusses the newly FDA approved immunotherapy combination, Empliciti® (elotuzumab), to treat certain patients with multiple myeloma who have received at least two prior therapies.   

Don Cummings, an LA-based playwright, discusses Peyronie’s Disease and his new book “Bent But Not Broken”. Peyronie’s Disease is a condition in which the development of fibrous scar tissue inside the penis causes curved, painful erections.

Dr. Charles Brenner, Chief Scientific Advisor at ChromaDex, and the Roy J. Carver Chair & Head of Biochemistry at the University of Iowa discusses a landmark first-of-a-kind preclinical study on lactating and breastfeeding rodent mothers that received a supplement of NR, nicotinamide riboside (Niagen) a unique B3 vitamin.

Returning guests, patient Christina Korines and John Lehr, CEO of the Parkinson’s Foundation, discuss statistics, women and Parkinson’s Disease (PD), genetics and PD, and the use of medical cannabis for those with PD.

President and CEO of the Muscular Dystrophy Association (MDA), Lynn O’Connor Vos, discusses the work that the organization is doing to fund research for neuromuscular diseases. MDA is the largest source of funding for neuromuscular disease research outside the federal government and has committed more than $1 billion in funding since its inception. Click here to find out more about the MDA Conference.

Flexion CEO Dr. Mike Clayman, discusses the company’s inflection year ahead, gene therapy, the importance of non-opioid options for people suffering from pain, and attracting/retaining talent in biotech/biopharma scene. Flexion is focused on advancing local therapies for patients with musculoskeletal disorders. The company’s non-opioid pain treatment, Zilretta, is an FDA approved intra-articular (“in the joint”) injection for pain due to osteoarthritis (OA) of the knee.